메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 28, Issue 3, 2010, Pages 387-391
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
Author keywords

[No Author keywords available]
Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;
EID: 75749096049     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.0712     Document Type: Article
Times cited : (171)
References (13)
  • 1
    • 0030910022 scopus 로고    scopus 로고
    • The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
    • Struewing JP, Hartge P, Wacholder S, et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408, 1997
    • (1997) N Engl J Med , vol.336 , pp. 1401-1408
    • Struewing, J.P.1    Hartge, P.2    Wacholder, S.3
  • 2
    • 0029794992 scopus 로고    scopus 로고
    • Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
    • Roa BB, Boyd AA, Vocik K, et al: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187, 1996
    • (1996) Nat Genet , vol.14 , pp. 185-187
    • Roa, B.B.1    Boyd, A.A.2    Vocik, K.3
  • 3
    • 0033927850 scopus 로고    scopus 로고
    • BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer
    • Moslehi R, Chu W, Karlan B, et al: BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 66:1259-1272, 2000
    • (2000) Am J Hum Genet , vol.66 , pp. 1259-1272
    • Moslehi, R.1    Chu, W.2    Karlan, B.3
  • 4
    • 0033591850 scopus 로고    scopus 로고
    • Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
    • Warner E, Foulkes W, Goodwin P, et al: Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241-1247, 1999
    • (1999) J Natl Cancer Inst , vol.91 , pp. 1241-1247
    • Warner, E.1    Foulkes, W.2    Goodwin, P.3
  • 5
    • 0034125402 scopus 로고    scopus 로고
    • A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes
    • Kuperstein G, Foulkes WD, Ghadirian P, et al: A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes. Clin Genet 57:213-220, 2000
    • (2000) Clin Genet , vol.57 , pp. 213-220
    • Kuperstein, G.1    Foulkes, W.D.2    Ghadirian, P.3
  • 6
    • 1842680082 scopus 로고    scopus 로고
    • A breast cancer prediction model incorporating familial and personal risk factors
    • Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111-1130, 2004
    • (2004) Stat Med , vol.23 , pp. 1111-1130
    • Tyrer, J.1    Duffy, S.W.2    Cuzick, J.3
  • 7
    • 67349122732 scopus 로고    scopus 로고
    • Differences and similarities in breast cancer risk assessment models in clinical practice: Which model to choose?
    • Jacobi CE, de Bock GH, Siegerink B, et al: Differences and similarities in breast cancer risk assessment models in clinical practice: Which model to choose? Breast Cancer Res Treat 115:381-390, 2009
    • (2009) Breast Cancer Res Treat , vol.115 , pp. 381-390
    • Jacobi, C.E.1    de Bock, G.H.2    Siegerink, B.3
  • 8
    • 0344442208 scopus 로고    scopus 로고
    • Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme
    • Amir E, Evans DG, Shenton A, et al: Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807-814, 2003
    • (2003) J Med Genet , vol.40 , pp. 807-814
    • Amir, E.1    Evans, D.G.2    Shenton, A.3
  • 9
    • 34247152144 scopus 로고    scopus 로고
    • Evaluation of mathematical models for breast cancer risk assessment in routine clinical use
    • Fasching PA, Bani MR, Nestle-Kramling C, et al: Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. Eur J Cancer Prev 16:216-224, 2007
    • (2007) Eur J Cancer Prev , vol.16 , pp. 216-224
    • Fasching, P.A.1    Bani, M.R.2    Nestle-Kramling, C.3
  • 10
    • 57649109447 scopus 로고    scopus 로고
    • Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study
    • Metcalfe KA, Fan I, McLaughlin J, et al: Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study. Gynecol Oncol 112:68-72, 2009
    • (2009) Gynecol Oncol , vol.112 , pp. 68-72
    • Metcalfe, K.A.1    Fan, I.2    McLaughlin, J.3
  • 11
    • 0035782961 scopus 로고    scopus 로고
    • Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors
    • Miesfeldt S, Cohn W, Ropka M, et al: Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors. Fam Cancer 1:135-141, 2001
    • (2001) Fam Cancer , vol.1 , pp. 135-141
    • Miesfeldt, S.1    Cohn, W.2    Ropka, M.3
  • 12
    • 0346252187 scopus 로고    scopus 로고
    • Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer
    • Pichert G, Dietrich D, Moosmann P, et al: Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Fam Cancer 2:153-158, 2003
    • (2003) Fam Cancer , vol.2 , pp. 153-158
    • Pichert, G.1    Dietrich, D.2    Moosmann, P.3
  • 13
    • 0035081287 scopus 로고    scopus 로고
    • Colorado family physicians' knowledge of hereditary breast cancer and related practice
    • Mouchawar J, Klein CE, Mullineaux L: Colorado family physicians' knowledge of hereditary breast cancer and related practice. J Cancer Educ 16:33-37, 2001
    • (2001) J Cancer Educ , vol.16 , pp. 33-37
    • Mouchawar, J.1    Klein, C.E.2    Mullineaux, L.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.